Federal University of Minas Gerais
ufmg.brTotal trials
148
Active
17
Phase 3
3
Total enrollment
18,161
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| topical placebo | — | — | — | — | — | 1 | |
| topical clonazepam | — | — | — | — | — | 1 | |
| Resomelagon | — | — | — | — | — | 1 | |
| Vivaxin vaccine manufactured by CT Vacinas/Cristália Laboratory | — | — | — | — | — | 1 |
Next readouts
- 2026-02-01
- 2026-03
- 2027-06
Top conditions
- Stroke7
- Periodontitis6
- Quality of Life5
- Obesity5
- Anxiety4
- Infertility4
- Cerebral Palsy4
- Parkinson Disease4
Frequently asked questions about Federal University of Minas Gerais
- How many clinical trials does Federal University of Minas Gerais have on ClinicalTrials.gov?
- Federal University of Minas Gerais is listed as the lead sponsor on 148 clinical trials in ClinicalTrials.gov, 17 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Federal University of Minas Gerais's trials are in Phase 3?
- 3 of Federal University of Minas Gerais's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Federal University of Minas Gerais focus on?
- Federal University of Minas Gerais's most-studied conditions on ClinicalTrials.gov are Stroke, Periodontitis, Quality of Life, Obesity, Anxiety.
- When are Federal University of Minas Gerais's next clinical trial readouts?
- Federal University of Minas Gerais has 3 upcoming primary-completion readouts tracked here; the soonest is “Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome”, expected around 2026-02-01.